mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0008 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |